Chia Tai Enterprises International Limited (CAIHF)

Market Cap	203.54M +335.7%
Revenue (ttm)	567.72M +154.6%
Net Income	30.44M +552.3%
EPS	0.12
Shares Out	n/a
PE Ratio	6.69
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	510
Average Volume	523
Open	0.2775
Previous Close	0.0100
Day's Range	0.2775 - 0.2800
52-Week Range	0.0100 - 0.2800
Beta	4.67
RSI	61.82
Earnings Date	Feb 24, 2026

About CAIHF

Chia Tai Enterprises International Limited manufactures and sells animal health products and chlortetracycline in Mainland China, the Asia Pacific, the Americas, Europe, and internationally. It operates through two segments, Biochemical and Industrial. The Biochemical segment products portfolio consists of CTC premix and CTC hydrochloride, which are used as feed additives to promote growth of livestock, prevent or cure animal diseases, and enhance feed efficiency under the Shihao and Citifac brand names. The Industrial segment engages in the sa...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Employees: 900
• Stock Exchange: OTCMKTS
• Ticker Symbol: CAIHF

Financial Performance

In 2024, CAIHF's revenue was $307.75 million, an increase of 76.89% compared to the previous year's $173.98 million. Earnings were $11.17 million, an increase of 337.45%.